glp 1 news Science's 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Disease Half of GLP-1 users ditch

Balsano, C., Liver-spleen axis in nonalcoholic fatty liver disease

Sold for Reserach Use Only / Not FDA Regulated Out of stock IGF-1 LR3 Overview IGF-1 LR3 is a research-grade peptide studied in laboratory models for its role in cell-signaling pathways, growth-factor activity, and nutrient-partitioning research

Here, we uncovered that ER suppressed ferroptosis in ER+ breast cancer

Bremelanotide is a melanocortin receptor agonist, primarily targeting the MC4 receptor in the hypothalamus a key brain region for sexual function

* Helps fade the appearance of dark spots and post-acne marks over time

One group has generated an osteoblast conditional knockout of igf-1 using a Col12 promoter to drive Cre recombinase activity (Govoni et al., 2007b)